title: A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage.
abstract: Twenty two patients were entered into a randomised controlled clinical trial comparing the efficacy of somatostatin and vasopressin in controlling acute variceal haemorrhage. Somatostatin was significantly more successful in controlling acute variceal haemorrhage than vasopressin (p = 0.003). Furthermore, no complications were observed during treatment with somatostatin.
authors.forename: S A
authors.initials: SA
authors.lastname: Jenkins
authors.forename: J N
authors.initials: JN
authors.lastname: Baxter
authors.forename: W
authors.initials: W
authors.lastname: Corbett
authors.forename: P
authors.initials: P
authors.lastname: Devitt
authors.forename: J
authors.initials: J
authors.lastname: Ware
authors.forename: R
authors.initials: R
authors.lastname: Shields
mesh_terms: D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004932:Esophageal and Gastric Varices / Q000517:prevention & control*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D012008:Recurrence; D013004:Somatostatin / Q000627:therapeutic use*; D014667:Vasopressins / Q000627:therapeutic use*
chemical_list: D014667:Vasopressins; D013004:Somatostatin